MiNK Therapeutics, Inc. - INKT
About Gravity Analytica
Recent News
- 06.18.2025 - MiNK Therapeutics Annual Shareholders Meeting
- 06.18.2025 - MiNK Therapeutics Annual Shareholders Meeting
- 06.10.2025 - MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
- 06.10.2025 - MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
- 06.02.2025 - MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients
- 06.02.2025 - MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients
- 05.15.2025 - MiNK Therapeutics First Quarter 2025 Financial Results
- 05.15.2025 - MiNK Therapeutics First Quarter 2025 Financial Results
- 05.15.2025 - MiNK Therapeutics Reports Q1 2025 Results and Highlights Clinical & Strategic Progress
- 05.15.2025 - MiNK Therapeutics Reports Q1 2025 Results and Highlights Clinical & Strategic Progress
Recent Filings
- 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.15.2025 - EX-99.1 EX-99.1
- 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 05.15.2025 - 8-K Current report